Latest Boxed warning Stories
NEW YORK, Jan. 9, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AMAG Pharmaceuticals, Inc. ("AMAG" or the "Company").
Wright & Schulte LLC Continues To Investigate Complaints That Janssen Pharmaceuticals Did Not Disclose The Lack of An Effective Means To Treat Uncontrolled Bleeding In Patients Taking Xarelto
What's safer: a newly approved drug or one that has been on the market much longer?
On June 26, the FDA informed that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.
A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON,
An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March
Public Citizen’s Call for Testosterone Heart Attack Warnings Follows Launch of FDA Investigation into Low T Heart Risks, Filing of Several AndroGel Lawsuits. New
The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems,
Law firm Zoll, Kranz & Borgess, LLC announces a possible case for patients suffering from negative side-effects from the anti-seizure drug, Potiga (ezogabine).
The United States Food and Drug Administration (FDA) has recently issued a Drug Safety Announcement and approved a Black Box Warning, one of the harshest warnings, for Pfizer’s antibiotic intravenous